Centre for Personalised Medicine - Clinical Decision Making and Patient Safety (CPM)
This project is supported by the European Union's INTERREG VA Programme, managed by the Special EU Programmes Body (SEUPB).
Personalised medicine is a research-based medical approach to guide clinical decisions to ensure a patient receives the right treatment at the right time is now recognised as a key priority internationally.
While the promises of personalised medicine are only now beginning to be realised in certain areas of cancer medicine in particular, other disease areas have been slow to adopt or benefit from this approach, partly because of a lack of appropriate clinical engagement.
This project will create the oft cited highly sought after ethos and environment needed if personalised medicine is to be adapted in the partner hospitals and in five disease areas that have not yet engaged the personalised medicine discipline.
This aim is to establish a Centre for Personalised Medicine; Clinical Decision Making and Patient Safety (CPM) which will dramatically enhance the regional capability while serving as a magnet for regional and FDI industry to create innovative products and new optimised care pathway tools in priority disease areas for patients and commercial benefit.
The five Research Clusters (RCs) will utilize the methods and technologies from personalised medicine and apply them to heart disease, emergency surgery, acute kidney injury, unscheduled care in diabetes and diagnostic accuracy in dementia. These are areas associated with significant clinical need and commercial potential and will benefit significantly from the interdisciplinary academic and commercial cross-border expertise and collaboration.
The major strength of the programme resides in the expertise of the assembled highly complementary multidisciplinary team of clinicians, academic researchers and enterprises. There are a total of 12 partners involved including Ulster University, Letterkenny Institute of Technology, University of Highlands and Islands, Western Health and Social Care Trust, Letterkenny University Hospital, NHS Highlands, Randox Laboratories Ltd, United Health Group/OPTUM, Clinishare Ltd, Healthcare Analytics, Northern Ireland Clinical Research Services Ltd, national University of Galway.
The immediate objectives are to:
- Improve the triage of patients with chest pain to allow more appropriate and rapid emergency referral for Primary Coronary Intervention
- Identify determinants of outcomes in emergency surgery to improve care pathways and reduce morbidity and mortality
- Earlier recognition of Acute Kidney Injury to reduce mortality, morbidity and hospital stay
- Improve the self-management of diabetes to reduce unscheduled care episodes and hospital admissions
- Develop tools which will allow earlier diagnosis of dementia and therefore earlier clinical intervention and support
The total costs of the project is €9,424,926 with INTERREG grant funding of €8,628,985.
This project is supported by the EU’s INTERREG VA Programme, managed by the Special EU Programmes Body